| 000 | 00853 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250512001537.0 | ||
| 264 | 0 | _c19870227 | |
| 008 | 198702s 0 0 eng d | ||
| 022 | _a0003-3197 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aReidenberg, M M | |
| 245 | 0 | 0 |
_aProcainamide, N-acetylprocainamide, antinuclear antibody and systemic lupus erythematosus. _h[electronic resource] |
| 260 |
_bAngiology _cDec 1986 |
||
| 300 |
_a968-71 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcecainide _xadverse effects |
| 650 | 0 | 4 | _aAcetylation |
| 650 | 0 | 4 |
_aAntibodies, Antinuclear _xbiosynthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xchemically induced |
| 650 | 0 | 4 |
_aProcainamide _xadverse effects |
| 700 | 1 | _aDrayer, D E | |
| 773 | 0 |
_tAngiology _gvol. 37 _gno. 12 Pt 2 _gp. 968-71 |
|
| 999 |
_c2440025 _d2440025 |
||